Lombard Medical Limited
Paul Hayes is currently the Chief Medical Officer at Thermology Health, Selentus Science Limited, PedraTech, and Lombard Medical Limited. With a background in Vascular and Endovascular Surgery, Paul has also worked as a Vascular and Endovascular Surgeon at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust. In addition, Paul has served in consultancy roles at Pathfinder Medical, Medtronic, and HAEMOSTATIX LIMITED, as well as on the Medical Advisory Board at Endologix, Inc. Paul holds a degree in Vascular Surgery from the Royal College of Surgeons of Edinburgh and a degree in Medicine from the University of Aberdeen.
This person is not in any teams
Lombard Medical Limited
Lombard Medical Limited is an Oxfordshire, UK-based medical device company focused on the market for minimally invasive treatment of aortic aneurysms (TAA/AAA). The Company has global regulatory approval for Aorfix™, an endovascular stent graft which has been specifically designed to treat patients with the broadest range of AAA anatomies, including aortic neck angulation up to 90 degrees. Lombard also manufactures the Altura™ stent graft, an innovative ultra-low profile device with a unique easy to use design that lends itself to day case EVAR, and which has been widely used in the repair of other failing EVAR devices. Lombard now also supplies the Minos™ ultra-low profile AAA stent graft, as well as the low profile Hercules™ TAA system. We continue to innovate and look for ways to enhance and increase the options physicians have to treat their patients.